← Back to Influence Map
Entity DossierOrganization
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
DC · US
no change
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$32,632,086
Connections
11
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$54.4MPHAPharmacy
$54.0MMMMMedicare/Medicaid
$53.2MBUDBudget/Appropriations
$120KTRATransportation
$0TAXTaxation/Internal Revenue Code
$0MANManufacturing
$0ACCACC
$0Lobbying Firms Retained
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION$53.2M
RYAN COSTELLO STRATEGIES$640K
EMERGENT STRATEGIES$520K
Mercury Public Affairs, LLC$240K
1607 STRATEGIES, LLC$180K
COLAS & ASSOCIATES, LLC$130K
THE GIBSON GROUP, LLC$100K
FORWARD GLOBAL$60K
Bills Referenced in Lobbying Filings
S. 832PBMinsulin
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31) | Source |
| Employed by | FORWARD GLOBAL | Hired FORWARD GLOBAL to lobby on PBM Reform Act | Source |
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,764,027 | Source |
| Lobbied for | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $4,112,554 | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Employed by | COLAS & ASSOCIATES, LLC | Hired COLAS & ASSOCIATES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2024) | Source |
| Employed by | Mercury Public Affairs, LLC | Hired MERCURY PUBLIC AFFAIRS, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Employed by | THE GIBSON GROUP, LLC | Hired THE GIBSON GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026) | Source |
| Employed by | 1607 STRATEGIES, LLC | Hired 1607 STRATEGIES, LLC to lobby (2nd Quarter (Apr 1 - June 30) 2023) | Source |
| Employed by | RYAN COSTELLO STRATEGIES | Hired RYAN COSTELLO STRATEGIES to lobby (3rd Quarter (July 1 - Sep 30) 2023) | Source |
| Employed by | EMERGENT STRATEGIES | Hired EMERGENT STRATEGIES to lobby (2nd Quarter (Apr 1 - June 30) 2024) | Source |